2.Molecular Epidemiology of Clinical Cryptococcus neoformans Isolates in Seoul, Korea.
So Hae PARK ; Mina KIM ; Sei Ick JOO ; Soo Myung HWANG
Mycobiology 2014;42(1):73-78
Cryptococcal infection is primarily caused by two species, Cryptococcus neoformans and C. gattii. Between the two species, C. neoformans var. grubii is the major causative agent of cryptococcosis in Asia. We investigated the molecular characteristics of 46 isolates of C. neoformans from patients with cryptococcosis between 2008 and 2012 in Seoul, Korea. All the isolates were determined to be C. neoformans var. grubii (serotype A), mating type MATalpha, and molecular type VNI by PCR-restriction fragment length polymorphism of the URA5 gene. Multilocus sequencing type (MLST) analysis using the International Society of Human and Animal Mycoses (ISHAM) consensus MLST scheme identified two sequence types (ST). Out of the 46 strains, 44 (95.7%) were identified as ST5, and remaining 2 were identified as ST31. Our study revealed that the clinical strains of C. neoformans in Korea are genetically homogeneous with the VNI/ST5 genotypes, and new appearance of VNI/ST31 genotype may serve as an important indicator of global genetic analysis.
Animals
;
Asia
;
Consensus
;
Cryptococcosis
;
Cryptococcus neoformans*
;
Cryptococcus*
;
Genotype
;
Humans
;
Korea
;
Molecular Epidemiology*
;
Mycoses
;
Seoul
3.Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies.
Xiao-Lei XU ; Ting ZHAO ; Vijay HARYPURSAT ; Yan-Qiu LU ; Yan LI ; Yao-Kai CHEN
Chinese Medical Journal 2020;133(23):2859-2866
The prevalence of asymptomatic cryptococcal antigenemia (ACA) in human immunodeficiency virus (HIV) infected individuals has been observed to be elevated. The prevalence of ACA ranges from 1.3% to 13%, with different rates of prevalence in various regions of the world. We reviewed studies conducted internationally, and also referred to two established expert consensus guideline documents published in China, and we have concluded that Chinese HIV-infected patients should undergo cryptococcal antigen screening when CD4 T-cell counts fall below 200 cells/μL and that the recommended treatment regimen for these patients follow current World Health Organization guidelines, although it is likely that this recommendation may change in the future. Early screening and optimized preemptive treatment for ACA is likely to help decrease the incidence of cryptococcosis, and is lifesaving. Further studies are warranted to explore issues related to the optimal management of ACA.
AIDS-Related Opportunistic Infections
;
CD4 Lymphocyte Count
;
China
;
Cryptococcosis/epidemiology*
;
Cryptococcus
;
HIV Infections/complications*
;
Humans
;
Meningitis, Cryptococcal